Skip to end of metadata
Go to start of metadata

You are viewing an old version of this page. View the current version.

Compare with Current View Page History

Version 1 Next »

Project Team Meeting: Agendas & Minutes

Our Project Team Meetings are held every Tuesday, 17:00-18:00 (Central European Time)

If you would like to participate, contact the Project Manager: richard.norman@pistoiaalliance.org

Name
Organisation
Location
Role
Relevant experience & interests
Qing Chai
Eli Lilly
San Diego, US


Craig Dickinson
Eli Lilly
San Diego, US


Francisco J. Fernández
Abvance Biotech
Madrid, ES
Chief Executive Officer
CEO. Structural biologist. Scientific leadership to the antibody drug discovery, business strategy and partnering programmes.
Laura Hook
GSK
Stevenage, UK


Bryan Jones
Eli Lilly
San Diego, US
Research Fellow
Group Leader for Protein Bio-Sciences group, responsible for expression, purification, biochemical and biophysical characterization of potential therapeutic proteins and antibodies.
Helen Li
Eli Lilly
San Diego, US


Chris Lloyd
MedImmune
Cambridge, UK

Protein engineer. Research Developability lead for MedImmune. Works on mAbs, bispecific's, ADCs and other novel formats across various therapy areas
Carmen Nitsche
Pistoia Alliance

Business Development Lead

Richard Norman
Pistoia Alliance
Gjøvik, NO
Consultant Project Manager
Project Manager. Background in structural biology, and small molecule drug discovery and early development at AstraZeneca. Interested in drug development of biologics, data sharing and the impact which Machine Learning and Artificial Intelligence will have on the Life Sciences.
Abhinandan Raghavan
Novartis
Basel, CH


Kieran Todd
GSK
Stevenage, UK
Senior Investigator
Bioinformatician providing support to all aspect of the antibody development process, ranging from target identification through to patent support but most heavily focused on lead molecule identification and/or design.
  • No labels